Birinyi Associates Inc Johnson & Johnson Transaction History

Birinyi Associates Inc

$345 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$155.22 - $162.74 $39,581 - $41,498	-255 Reduced 14.11%	1,552 $245,000
Q4 2023 Jan 10, 2024	BUY	$145.6 - $158.88 $582 - $635	4 Added 0.22%	1,807 $283,000
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $15,730 - $17,622	101 Added 5.93%	1,803 $280,000
Q2 2023 Aug 08, 2023	SELL	$154.35 - $166.11 $385,566 - $414,942	-2,498 Reduced 59.48%	1,702 $281,000
Q4 2022 Feb 08, 2023	SELL	$160.2 - $179.79 $640,800 - $719,160	-4,000 Reduced 48.78%	4,200 $741,000
Q3 2022 Nov 08, 2022	BUY	$161.33 - $179.52 $887,315 - $987,360	5,500 Added 203.7%	8,200 $1.34 Million
Q4 2021 Jan 26, 2022	SELL	$155.93 - $173.01 $38,982 - $43,252	-250 Reduced 8.47%	2,700 $462,000
Q2 2020 Aug 06, 2020	SELL	$128.81 - $155.51 $611,847 - $738,672	-4,750 Reduced 61.69%	2,950 $415,000
Q1 2020 May 12, 2020	SELL	$111.14 - $153.99 $111,140 - $153,990	-1,000 Reduced 11.49%	7,700 $1.01 Million
Q2 2019 Aug 05, 2019	SELL	$131.15 - $144.24 $98,362 - $108,180	-750 Reduced 7.94%	8,700 $1.21 Million
Q1 2019 May 08, 2019	SELL	$125.72 - $139.79 $377,160 - $419,370	-3,000 Reduced 24.1%	9,450 $1.32 Million
Q4 2018 Feb 07, 2019	BUY	$122.84 - $147.84 $337,810 - $406,560	2,750 Added 28.35%	12,450 $1.61 Million
Q3 2018 Nov 01, 2018	BUY	$121.58 - $142.88 $60,790 - $71,440	500 Added 5.43%	9,700 $1.34 Million
Q2 2018 Aug 10, 2018	SELL	$119.4 - $131.76 $59,700 - $65,880	-500 Reduced 5.15%	9,200 $1.12 Million
Q1 2018 Apr 26, 2018	SELL	$125.1 - $148.14 $93,825 - $111,104	-750 Reduced 7.18%	9,700 $1.24 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $97,102 - $101,535	-750 Reduced 6.7%	10,450 $1.36 Million
Q2 2017 Aug 08, 2017	BUY	N/A	11,200	11,200 $1.48 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birinyi Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Birinyi Associates Inc with notifications on news.

Account